Torrent Pharmaceuticals share news, announcements and annual reports
NSE: TORNTPHARMBSE: 500420Pharmaceuticals & BiotechnologyLarge Cap
Share price at the NSE close on 2 Nov 2026. Previous close ₹4,613.40.
2 Nov: open ₹4,636.50, high ₹4,675.00, low ₹4,553.00
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,74,779 Cr61st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 82.29
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 9.51
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.83%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 15.8%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 12.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.76
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 3,55,935
Torrent Pharmaceuticals share news and announcements
865 announcements, routine notices left out, newest first. Page 9 of 18.
Jan 2021
Dec 2020
16 Dec · Updates
9 Dec · Updates
2 Dec · Analysts
Nov 2020
21 Nov · Analysts
19 Nov · Analysts
11 Nov · Related Party Transactions
Oct 2020
26 Oct · Results
15 Oct · Analysts
13 Oct · Board meeting
Sep 2020
27 Sep · Analysts
Aug 2020
27 Aug · Rating
26 Aug · Rating
Jul 2020
30 Jul · Meeting
30 Jul · Results
14 Jul · Board meeting
Jun 2020
24 Jun · Related Party Transactions
May 2020
26 May · Results
20 May · Analysts
18 May · Board meeting
14 May · Issue of Securities
8 May · Rating
Apr 2020
24 Apr · Issue of Securities
22 Apr · Rating
4 Apr · Updates
Mar 2020
24 Mar · Redemption
11 Mar · Dividend
7 Mar · Meeting
7 Mar · Meeting
4 Mar · Corporate action
3 Mar · Board meeting
Feb 2020
4 Feb · Meeting
Jan 2020
28 Jan · Corporate action
27 Jan · Board meeting
27 Jan · Management
27 Jan · Results
20 Jan · Analysts